Synergy Pharmaceuticals Wins Approval for Bankruptcy Loan Drugmaker can draw down remainder of $155 million financing package over protests from shareholders
By Tom Corrigan Feb. 22, 2019 5:48 p.m. ET
Synergy Pharmaceuticals Inc. won court permission to draw down the remainder of a $155 million bankruptcy financing package, overcoming roadblocks imposed by a newly empowered committee of shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.